Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aldara vs Solaraze for Actinic Keratosis (LEIDA 2)
NCT01453179Phase 4Completed
- Sponsor
- Meda
- Start
- Oct 2011
- Primary completion
- Mar 2015
- Modality
- Nucleic Acid-Directed Small Molecules, Irreversible Covalent Inhibitors, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 4 trial of imiquimod in actinic keratosis (AK), sponsored by Meda. Started Oct 2011; status: completed.
02
Drugs
imiquimod
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT01453179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01453179.